Study Conduct

INC Research, CISCRP launch ideathon to boost awareness of clinical research

Friday, May 20, 2016

INC Research Holdings, a global phase I to IV CRO, together with the Center for Information and Study on Clinical Research Participation (CISCRP), a nonprofit organization dedicated to engaging the public and patients as partners in the clinical research process, have announced an innovative new initiative designed to promote greater awareness of the importance of clinical trial participation in advancing public health.

[Read More]

DCRI, SAS open heart-disease data to researchers

Monday, May 9, 2016

A new collaboration between the Duke Clinical Research Institute (DCRI) and SAS will give more researchers access to the largest and oldest cardiovascular database in the world. The DCRI and analytics leader SAS will provide researchers worldwide with data management and analytics tools to explore 45 years of cardiovascular patient data collected by the Duke University Health System.

[Read More]

PharmaSeek, PRCCI partner on Puerto Rico

Monday, May 2, 2016

PharmaSeek, an Investigative Site Network (ISN), is expanding the reach of its network by partnering with the Puerto Rico Consortium for Clinical Investigation (PRCCI). PRCCI is a newly established nonprofit government trust comprised of multiple clinical research sites throughout Puerto Rico. Through a collaborative network of investigators and the support of PharmaSeek, PRCCI hopes to promote and enhance clinical research and drug development in Puerto Rico.

[Read More]

MSOAC launches database for MS clinical trial data

Tuesday, April 26, 2016

A new database containing nearly 2500 patient records from the placebo arms of nine multiple sclerosis (MS) clinical trials is now available for research by qualified investigators. This is just one of the tools generated through the Multiple Sclerosis Outcome Assessments Consortium (MSOAC), a global effort launched by the National MS Society and Critical Path Institute (C-Path). MSOAC is striving to develop an outcomes measure that addresses the critical need for a more sensitive way to detect the benefit of potential treatments that slow or reverse progressive disability in people with MS.

[Read More]

Bioclinica, ArisGlobal partner on pharmacovigilance model

Wednesday, April 20, 2016

Bioclinica, a specialty clinical trials technology and services provider, has announced the selection of ArisGlobal‘s Safety Cloud as the preferred safety platform for its pharmacovigilance services. Under this partnership, Bioclinica becomes the preferred partner for ArisGlobal in business process consulting and change management as sponsors implement or upgrade ARISg. Together the partnership brings a flexible delivery model that fits any organization regardless of size or case volume.

[Read More]

Veteran Affairs, Seven Bridges partner on Million Veteran Program

Monday, April 11, 2016

Seven Bridges, a biomedical data analysis company, has signed a Collaborative Research and Development Agreement (CRADA) with the U.S. Department of Veteran Affairs (VA) to support two key research initiatives for the VA’s Million Veteran Program (MVP). The MVP is a national, voluntary research program funded by the VA’s Office of R&D, with the goal of partnering with Veterans receiving their care from the VA Healthcare System to study how genes affect health. Seven Bridges will serve as an industrial collaborator on the MVP, supporting the development of a hybrid cloud for large-scale data analysis, and a genotype-phenotype graph analysis engine.

[Read More]